THDBH-120/THDBH-121

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTHDBH-120/THDBH-121
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsWeight LossObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Apptec Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDongbao Zixing (Hangzhou) Biological Medicine Co LtdWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsWeight LossObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A